Beginning Cash: The amount of cash reported by the company on its previous statement.
Tourmaline Bio, Inc. (TRML) had Beginning Cash of $30.73M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-23.09M |
|
-- |
|
-- |
|
$25.97M |
|
$-25.97M |
|
$2.88M |
|
$-23.09M |
|
$-23.09M |
|
$-23.09M |
|
$-23.09M |
|
$-23.09M |
|
$-23.09M |
|
$-25.97M |
|
$-27.40M |
|
25.75M |
|
25.75M |
|
$-0.90 |
|
$-0.90 |
|
| Balance Sheet Financials | |
$249.10M |
|
$0.05M |
|
$20.19M |
|
$269.30M |
|
$10.10M |
|
-- |
|
$0.01M |
|
$10.10M |
|
$259.19M |
|
$259.19M |
|
$259.19M |
|
25.69M |
|
| Cash Flow Statement Financials | |
$-41.94M |
|
$42.24M |
|
$0.62M |
|
|
Beginning Cash |
$30.73M |
$31.65M |
|
$0.92M |
|
$4.74M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
24.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-41.96M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.91% |
|
-8.91% |
|
-8.57% |
|
-8.91% |
|
$10.09 |
|
$-1.63 |
|
$-1.63 |
|